Literature DB >> 33462714

Clear cell carcinoma of the urinary bladder: a systematic review.

Erica On-Ting Chan1, Vinson Wai-Shun Chan2, Jade Yin-To Poon1, Brian Hang-Kin Chan1, Chun-Pong Yu3, Peter Ka-Fung Chiu1, Chi-Fai Ng1, Jeremy Yuen-Chun Teoh4.   

Abstract

PURPOSE: We conducted a systematic review of the literature on primary clear cell carcinoma (CCC) of the urinary bladder.
METHODS: A literature search using keywords and MeSH terms related to "clear cell carcinoma", "clear cell adenocarcinoma", "mesonephroma" and "urinary bladder" in EMBASE, MEDLINE and Cochrane Central Register of Controlled Trials was performed. A manual search was performed with web-based search engine Google Scholar. Reference lists of the included studies were screened for additional articles. Articles up till 16th July 2020 were retrieved. Observational human studies on primary CCC in urinary bladder with English full-text were included for further analysis.
RESULTS: 904 articles were identified and 44 articles were included for further analysis. Data including clinical features, tumour characteristics, treatment and oncological outcomes were reviewed. There were 70 patients (44 females and 26 males) reported in literatures and included in this review. Gross haematuria was the most common presentation (79.7%), followed by irritative urinary symptoms (47.5%). Regarding the histology, tubulocystic pattern is the most common histologic pattern (49.1%), and 52.6% had muscle invasion. Most cases were CK7 (96.6%) and CK20 (88.9%) positive. CA125 (96%) was commonly positive, indicating its potential origin from mullerian duct. Most patients received surgery (95.5%) as primary treatment. However, the oncological outcomes were unsatisfactory with a 2-year survival rate of 60.0%.
CONCLUSION: Clear cell carcinoma is an uncommon subtype of bladder cancer which can be diagnosed by histology and immunohistochemical staining result. The majority of patients presented with muscle invasion and had a poor survival despite aggressive treatment.

Entities:  

Keywords:  Bladder cancer; Clear cell carcinoma; Systematic review; Urinary bladder

Year:  2021        PMID: 33462714     DOI: 10.1007/s11255-020-02725-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

1.  Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.

Authors:  Ming-Tse Sung; Shaobo Zhang; Gregory T MacLennan; Antonio Lopez-Beltran; Rodolfo Montironi; Mingsheng Wang; Puay-Hoon Tan; Liang Cheng
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

Review 2.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.

Authors:  Peter A Humphrey; Holger Moch; Antonio L Cubilla; Thomas M Ulbright; Victor E Reuter
Journal:  Eur Urol       Date:  2016-03-17       Impact factor: 20.096

3.  Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

4.  Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.

Authors:  E Oliva; R H Young
Journal:  Mod Pathol       Date:  1996-05       Impact factor: 7.842

5.  Primary clear cell carcinoma of urinary bladder: A case report.

Authors:  Mahmoudreza Moradi; Shahram Shojaei; Kaveh Kaseb; Haress Rezaee
Journal:  Urol Case Rep       Date:  2017-10-19

6.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
  6 in total
  1 in total

1.  Female patient's outcome of primary bladder clear cell carcinoma managed with radical cystectomy:A case report.

Authors:  Xue-Bin Wang; Bin Jiang
Journal:  Urol Case Rep       Date:  2022-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.